Erythropoiesis Stimulating Agent ESA Dosing and Administration in Adult Patients with Chronic Kidney Disease CKD v2
Preview
Erythropoiesis Stimulating Agent ESA Dosing and Administration in Adult Patients with Chronic Kidney Disease CKD v2 Download
Overview
To ensure all Healthcare professionals are aware of the best practice for the administration of an ESA to patients with anaemia of CKD. To know when to seek advice NMC code of Conduct “Know your Capabilities” 2015: 6.3
Categories
ClinicalReference
Date Uploaded
30.11.2021Date Review
29.11.2024File Size
922KbClinical Guidelines
This guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.